Russia has released new results claiming its experimental coronavirus vaccine is highly effective and will cost less than vaccines made by some Western competitors.
Subscribe now for unlimited access.
or signup to continue reading
Russian Direct Investment Fund, which bankrolled the development of the shot, says Sputnik V will cost less than $US10 ($A14) per dose - or less than $US20 for the two doses needed to vaccinate one person - on international markets.
The vaccine will be free for Russians. Developers of the vaccine say it was 91.4 per cent effective, according to new trial data.
Pfizer and Moderna shots cost about $US20 and $US15-25 per dose respectively, based on agreements the companies have struck to supply their vaccines to the US government.
Russia drew international criticism for giving Sputnik V regulatory approval before it underwent advanced testing among tens of thousands of people required to ensure its safety and effectiveness.
Russia has reported 2.1 million confirmed cases and more than 36,000 deaths, according to data from Johns Hopkins University.
Australian Associated Press
